About MenoGeniX
MenoGeniX is a company based in Aurora (United States) founded in 2010.. MenoGeniX has raised $1.18 million across 7 funding rounds from investors including HHS. MenoGeniX offers products and services including MNGX-100. MenoGeniX operates in a competitive market with competitors including Amyris, Avidity Biosciences, Arbor Biotechnologies, Univercells and Sutro Biopharma, among others.
- Headquarter Aurora, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Menogenix, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.18 M (USD)
in 7 rounds
-
Latest Funding Round
$299.83 K (USD), Grant
Jun 01, 2020
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MenoGeniX
MenoGeniX offers a comprehensive portfolio of products and services, including MNGX-100. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Potential alternative therapy for hot flashes and vasomotor symptoms in menopause
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of MenoGeniX
MenoGeniX has successfully raised a total of $1.18M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $299.83 thousand completed in June 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Grant — $299,831
-
First Round
First Round
(30 Jul 2012)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2020 | Amount | Grant - MenoGeniX | Valuation |
investors |
|
| Jan, 2018 | Amount | Grant - MenoGeniX | Valuation |
investors |
|
| Dec, 2017 | Amount | Seed - MenoGeniX | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MenoGeniX
MenoGeniX has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MenoGeniX
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - MenoGeniX
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Menogenix Comparisons
Competitors of MenoGeniX
MenoGeniX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Avidity Biosciences, Arbor Biotechnologies, Univercells and Sutro Biopharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of renewable products for industrial solutions
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Genomic technologies and drug discovery platforms are provided.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Menogenix
Frequently Asked Questions about MenoGeniX
When was MenoGeniX founded?
MenoGeniX was founded in 2010 and raised its 1st funding round 2 years after it was founded.
Where is MenoGeniX located?
MenoGeniX is headquartered in Aurora, United States. It is registered at Aurora, Colorado, United States.
Who is the current CEO of MenoGeniX?
Richard C Duke is the current CEO of MenoGeniX.
Is MenoGeniX a funded company?
MenoGeniX is a funded company, having raised a total of $1.18M across 7 funding rounds to date. The company's 1st funding round was a Seed of $75K, raised on Jul 30, 2012.
What does MenoGeniX do?
MenoGeniX was founded in 2010 and is based in Aurora, United States, as a clinical-stage biotechnology company. Treatments for menopause and associated symptoms in breast and prostate cancer patients are developed. The product pipeline features MNGX-100, a reformulated biological therapy with Phase 1b completed in 2014, currently advancing through Phase 2 trials for hot flashes and vasomotor symptoms. Operations focus on drug development in the womens health and oncology sectors.
Who are the top competitors of MenoGeniX?
MenoGeniX's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.
What products or services does MenoGeniX offer?
MenoGeniX offers MNGX-100.
Who are MenoGeniX's investors?
MenoGeniX has 1 investor. Key investors include HHS.